Luhong formula inhibits ferroptosis via the SLC7A11/GPX4 axis to protect against myocardial ischemia/reperfusion injury

Luhong Formula ( LHF) is a traditional Chinese herbal formula historically used to support heart function and improve circulation. This study provides scientific evidence for its cardioprotective role against myocardial ischemia/reperfusion injury through the inhibition of ferroptosis. Ferroptosis, a form of regulated cell death characterized by iron accumulation and lipid peroxidation, plays a critical role in myocardial ischemia/reperfusion (I/R) injury. However, effective strategies to attenuate ferroptosis-induced cardiac damage remain limited. This study aimed to explore the cardioprotective effects of LHF and its underlying mechanisms in suppressing ferroptosis. In vivo, I/R was developed by ligating and then releasing the left anterior descending artery. Heart tissue and blood were collected 24 h post-reperfusion to evaluate cardiac injury and ferroptosis. In vitro, neonatal rat cardiomyocytes were isolated to create a hypoxia/reoxygenation model. By overexpressing and/or silencing SLC7A11 in cardiomyocytes, we assessed the impact of LHF intervention on cellular damage, ferroptosis, and SLC7A11 degradation. LHF significantly improved cardiac function, reduced infarct size, and attenuated oxidative stress and ferroptosis both in vivo and in vitro. Mechanistically, LHF upregulated the expression of SLC7A11 and GPX4, restored antioxidant capacity, and reduced Fe 2+ overload and lipid peroxidation. Overexpression of SLC7A11 mimicked the protective effects of LHF, while SLC7A11 knockdown abolished them. Notably, LHF reduced the ubiquitination of SLC7A11, suggesting that it enhances SLC7A11 stability and function under stress conditions. LHF protects against myocardial I/R injury by inhibiting ferroptosis through activation of the SLC7A11/GPX4 axis. These findings highlight SLC7A11 as a potential therapeutic target and provide novel insights into the anti-ferroptotic mechanisms of traditional Chinese medicine.

Authors

Institutions

Publication Details

Journal
Journal of Radiation Research and Applied Sciences
Published
2026-02-23
DOI
https://doi.org/10.1016/j.jrras.2026.102225
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Luhong formula inhibits ferroptosis via the SLC7A11/GPX4 axis to protect against myocardial ischemia/reperfusion injury

Wan Cai, Yi-Xiang Wang, Yu Hang, Wentao Fu et al.
Journal of Radiation Research and Applied Sciences
Ferroptosis and cancer prognosis
article

Luhong formula inhibits ferroptosis via the SLC7A11/GPX4 axis to protect against myocardial ischemia/reperfusion injury

Wan Cai, Yi-Xiang Wang, Yu Hang, Wentao Fu, Yaozhong Zhou
article en

Abstract

Luhong Formula ( LHF) is a traditional Chinese herbal formula historically used to support heart function and improve circulation. This study provides scientific evidence for its cardioprotective role against myocardial ischemia/reperfusion injury through the inhibition of ferroptosis. Ferroptosis, a form of regulated cell death characterized by iron accumulation and lipid peroxidation, plays a critical role in myocardial ischemia/reperfusion (I/R) injury. However, effective strategies to attenuate ferroptosis-induced cardiac damage remain limited. This study aimed to explore the cardioprotective effects of LHF and its underlying mechanisms in suppressing ferroptosis. In vivo, I/R was developed by ligating and then releasing the left anterior descending artery. Heart tissue and blood were collected 24 h post-reperfusion to evaluate cardiac injury and ferroptosis. In vitro, neonatal rat cardiomyocytes were isolated to create a hypoxia/reoxygenation model. By overexpressing and/or silencing SLC7A11 in cardiomyocytes, we assessed the impact of LHF intervention on cellular damage, ferroptosis, and SLC7A11 degradation. LHF significantly improved cardiac function, reduced infarct size, and attenuated oxidative stress and ferroptosis both in vivo and in vitro. Mechanistically, LHF upregulated the expression of SLC7A11 and GPX4, restored antioxidant capacity, and reduced Fe 2+ overload and lipid peroxidation. Overexpression of SLC7A11 mimicked the protective effects of LHF, while SLC7A11 knockdown abolished them. Notably, LHF reduced the ubiquitination of SLC7A11, suggesting that it enhances SLC7A11 stability and function under stress conditions. LHF protects against myocardial I/R injury by inhibiting ferroptosis through activation of the SLC7A11/GPX4 axis. These findings highlight SLC7A11 as a potential therapeutic target and provide novel insights into the anti-ferroptotic mechanisms of traditional Chinese medicine.

Journal of Radiation Research and Applied SciencesVol. 19(1)
Shanghai University of Traditional Chinese Medicine (CN), Changshu No.1 People's Hospital (CN), Shanghai Traditional Chinese Medicine Hospital (CN), Shuguang Hospital (CN)
Good health and well-being
Openalex Percentile: Top 46%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.